IP Library Granted Patent US 9,175,095
Granted Patent B2
US 9,175,095 · App. 13/875,966 · Granted Nov 3, 2015

Light-activated chimeric opsins and methods of using the same

Inventors: Karl Deisseroth (Stanford, CA); Ofer Yizhar (Palo Alto, CA); Lief Fenno (San Francisco, CA); Peter Hegemann (Falkensee, DE); Matthias Prigge (Berlin, DE)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C07K19/00C07K14/405C12N13/00G01N33/5058A01K2217/052A01K2227/105A01K2267/0393
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,175,095
App. No.
13/875,966
Granted
Nov 3, 2015
Kind
B2
Abstract

Provided herein are compositions comprising light-activated chimeric proteins expressed on plasma membranes and methods of using the same to selectively depolarize excitatory or inhibitory neurons.

Claims (19)

1. An isolated light-responsive chimeric polypeptide comprising an amino acid sequence having at least 95% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

2. The chimeric polypeptide of claim 1 , wherein the polypeptide is activated by light of a wavelength between about 540 nm to about 560 nm.

3. The chimeric polypeptide of claim 1 , further comprising a C-terminal trafficking signal.

4. The chimeric polypeptide of claim 3 , wherein the trafficking signal comprises the amino acid sequence KSRITSEGEYIPLDQIDINV (SEQ ID NO:15).

5. The chimeric polypeptide of claim 1 , wherein the light-responsive chimeric polypeptide comprises an amino acid sequence having at least 98% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

6. The chimeric polypeptide of claim 1 , wherein the polypeptide comprises a Glu to Thr amino acid substitution at position 122 relative to the amino acid sequence set forth in SEQ ID NO:1.

7. The chimeric polypeptide of claim 1 , wherein the polypeptide comprises a Glu to Thr amino acid substitution at position 162 relative to the amino acid sequence set forth in SEQ ID NO:1.

8. The chimeric polypeptide of claim 1 , wherein the polypeptide comprises a Glu to Thr amino acid substitution at position 122 and a Glu to Thr amino acid substitution at position 162 relative to the amino acid sequence set forth in SEQ ID NO:1.

9. The chimeric polypeptide of claim 1 , wherein the light-responsive chimeric polypeptide comprises an amino acid sequence having at least 99% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

10. An isolated polynucleotide comprising a nucleotide sequence encoding a light-responsive chimeric polypeptide comprising an amino acid sequence having at least 95% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

11. The isolated polynucleotide of claim 10 , wherein the nucleotide sequence is operably linked to a promoter.

12. The polynucleotide of claim 10 , wherein the polynucleotide is an expression vector.

13. The polynucleotide of claim 12 , wherein the expression vector is a viral vector.

14. The isolated polynucleotide of claim 10 , wherein the light-responsive chimeric polypeptide comprises an amino acid sequence having at least 98% amino acid sequence identity to the amino acid sequence set forth in SEQ ID NO:1.

15. The isolated polynucleotide of claim 10 , wherein the light-responsive chimeric polypeptide further comprises a C-terminal trafficking signal.

16. The isolated polynucleotide of claim 15 , wherein the trafficking signal comprises the amino acid sequence KSRITSEGEYIPLDQIDINV (SEQ ID NO:15).

17. The isolated polynucleotide of claim 10 , wherein the light-responsive chimeric polypeptide comprises a Glu to Thr amino acid substitution at position 122 relative to the amino acid sequence set forth in SEQ ID NO:1.

18. The isolated polynucleotide of claim 10 , wherein the light-responsive chimeric polypeptide comprises a Glu to Thr amino acid substitution at position 162 relative to the amino acid sequence set forth in SEQ ID NO:1.

19. The isolated polynucleotide of claim 10 , wherein the light-responsive chimeric polypeptide comprises a Glu to Thr amino acid substitution at position 122 and a Glu to Thr amino acid substitution at position 162 relative to the amino acid sequence set forth in SEQ ID NO:1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2015
From: DEISSEROTH, KARL; YIZHAR, OFER; FENNO, LIEF; HEGEMANN, PETER; PRIGGE, MATTHIAS
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 036453/0206 →
Continuity (5)
Continuation PCTUS2011059276 · Nov 4, 2011
Provisional Application 61511912 · Jul 26, 2011
Provisional Application 61410744 · Nov 5, 2010
Provisional Application 61410736 · Nov 5, 2010
Related Publication 20130224821A1 · Aug 29, 2013